Home / Companies / News / Dr Reddy's Lab expects to launch 25 products in US this fiscal year

Dr Reddy's Lab expects to launch 25 products in US this fiscal year

The drug major has also earmarked a capital expenditure (capex) of Rs 1,000 crore for finding various projects during the ongoing financial year

Premium

Dr Reddy's Laboratories reported revenues of Rs 17,460 crore for the financial year 2019-20.

3 min read Last Updated : Jun 28 2020 | 2:43 PM IST

Dr Reddy's Laboratories expects to launch 25 products in the US market in the current financial year, according to a top company official.

The drug major has also earmarked a capital expenditure (capex) of Rs 1,000 crore for finding various projects during the ongoing financial year.

"On a full-year basis (2019-20), we launched 27 products, including four re-launch of the earlier discontinued products. We expect the new launches momentum to continue during the year with about 25 product launches lined up despite uncertainty due to Covid-19," Dr Reddy's Laboratories CEO Erez Israeli said in an analyst call.

As of March

Topics : Dr Reddy's Laboratories United States

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in